AGT and Other metabolic disease: Additionally, aging and metabolic diseases are known to potentiate fibroblast activation [11]; therefore, incorporating aged cohorts and models of comorbid conditions (e.g., diabetes, hypertension) will be important to further define how these systemic factors shape PostnLin cell activation and fibrogenic response to AngII.